Ustekinumab ‘might trigger CV events’ in at-risk patients
Caution might be needed if initiating the biologic in patients with cardiovascular risk factors or history, say researchers.
Tag: Biologics
Patients give biologics a good rap on social media
And positive comments just outweigh negatives for conventional DMARDs too, analysis shows.
COVID-19: Rheumatology patient outcomes vary with meds
Overall, it seems DMARDs are not raising risk of severe infection, researchers say.
One biologic comes out on top in psoriatic arthritis trial
It's the first direct comparison of adalimumab and ixekizumab for the condition.
Ustekinumab beats placebo for ulcerative colitis
International trial showed subcutaneous maintenance therapy to be effective.
Biologic reduces nasal polyp size in rhinosinusitis
Two trials show dupilumab is an effective treatment for severe chronic rhinosinusitis.
How effective are TNF inhibitors in axial spondyloarthritis?
Study of more than 24,000 registry patients shows real-world efficacy and adherence.
Methotrexate-biologic combo gives improved outcomes in early RA
Pooled data from 13 studies shows better scores with combination therapy.
Are anti-TNF ‘non-responders’ being classified correctly?
Real-world study finds some of the patients appear to have low disease activity.
